Cargando…
Myopia control utilizing low-dose atropine as an isolated therapy or in combination with other optical measures: A retrospective cohort study
PURPOSE: To assess the additive potency of low-dose atropine combined with optical measures designed to decrease myopia progression. MATERIALS AND METHODS: This retrospective study included 104 myopic children aged 5–12 over 4 years, divided into five groups: daily instillation of 0.01% atropine and...
Autores principales: | Erdinest, Nir, London, Naomi, Lavy, Itay, Levinger, Nadav, Pras, Eran, Morad, Yair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361442/ https://www.ncbi.nlm.nih.gov/pubmed/37484626 http://dx.doi.org/10.4103/tjo.tjo_31_22 |
Ejemplares similares
-
Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022) -
Treatment of Rapid Progression of Myopia: Case Series and Literature Review
por: Erdinest, Nir, et al.
Publicado: (2021) -
Myopia Control with Combination Low-Dose Atropine and Peripheral Defocus Soft Contact Lenses: A Case Series
por: Erdinest, Nir, et al.
Publicado: (2021) -
Low-Concentration Atropine Monotherapy vs. Combined with MiSight 1 Day Contact Lenses for Myopia Management
por: Erdinest, Nir, et al.
Publicado: (2022) -
Peripheral Defocus and Myopia Management: A Mini-Review
por: Erdinest, Nir, et al.
Publicado: (2023)